In this Issue:
Second-line rituximab for adult ITP
Chlorambucil ±ofatumumab in previously untreated CLL
Carfilzomib/melphalan/ prednisone in elderly new MM
Nonmyeloablative HLA haploidentical blood/marrow transplant with high-dose cyclophosphamide
Post-remission approaches for AML
Imatinib for CML over 10 years
Allogeneic SCT and survival in primary myelofibrosis
Autologous SCT without transfusions for haematological malignancies
Ibrutinib plus chemoimmunotherapy in CLL
Please login below to download this issue (PDF)